PDS Biotechnology Corp.
(NASDAQ : PDSB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.28%163.380.7%$1113.05m
MRKMerck & Co., Inc. -0.91%76.050.7%$1036.64m
PFEPfizer Inc. 0.35%39.560.9%$943.89m
LLYEli Lilly & Co. -0.77%220.951.1%$935.83m
ABBVAbbVie, Inc. -0.31%114.381.9%$737.45m
BMYBristol-Myers Squibb Co. -1.65%65.731.0%$633.51m
AZNAstraZeneca Plc -0.94%57.761.2%$389.00m
OGN 0.58%29.580.0%$292.39m
NVSNovartis AG -0.84%93.120.2%$180.09m
GSKGlaxoSmithKline Plc -1.85%39.050.2%$161.56m
ANVSAnnovis Bio, Inc. -9.87%86.610.0%$146.09m
NOVNNovan, Inc. 0.77%10.475.8%$141.58m
ORPHOrphazyme A/S -7.98%6.000.0%$136.31m
CNSTConstellation Pharmaceuticals, Inc. -0.12%33.760.0%$112.69m
CVACCureVac NV -4.31%57.100.0%$109.47m

Company Profile

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.